An insight into light as a chronobiological therapy in affective disorders

References

• Baron KG, Reid KJ. Circadian misalignment and health. Int Rev Psychiatry. 2014;26(2):139–154.
   PubMed Web of Science ®Google Scholar
• Farajnia S, Deboer T, Rohling JH, Meijer JH, Michel S. Aging of the suprachiasmatic clock. Neuroscientist. 2014;20(1):44–55.
   Web of Science ®Google Scholar
• Asarnow LD, Soehner AM, Harvey AG. Basic sleep and circadian science as building blocks for behavioral interventions: a translational approach for mood disorders. Behav Neurosci. 2014;128(3):360–370.
   Web of Science ®Google Scholar
• Ralph MR, Lehman MN. Transplantation: a new tool in the analysis of the mammalian hypothalamic circadian pacemaker. Trends Neurosci. 1991;14(8):362–366.
   Web of Science ®Google Scholar
• Brown TM, Piggins HD. Electrophysiology of the suprachiasmatic circadian clock. Prog Neurobiol. 2007;82(5):229–255.
   Web of Science ®Google Scholar
• Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol. 2001;63:647–676.
   PubMed Web of Science ®Google Scholar
• Shibata S, Oomura Y, Kita H, Hattori K. Circadian rhythmic changes of neuronal activity in the suprachiasmatic nucleus of the rat hypothalamic slice. Brain Res. 1982;247(1):154–158.
   PubMed Web of Science ®Google Scholar
• Lall GS, Atkinson LA, Corlett SA, Broadbridge PJ, Bonsall DR. Circadian entrainment and its role in depression: a mechanistic review. J Neural Transm. 2012;119(10):1085–1096.
   Web of Science ®Google Scholar
• Foster RG. Shedding light on the biological clock. Neuron. 1998;20(5):829–832.
   Web of Science ®Google Scholar
• Lucas RJ, Foster RG. Neither functional rod photoreceptors nor rod or cone outer segments are required for the photic inhibition of pineal melatonin. Endocrinology. 1999;140(4):1520–1524.
   PubMed Web of Science ®Google Scholar
• Lucas RJ, Lall GS, Allen AE, Brown TM. How rod, cone, and melanopsin photoreceptors come together to enlighten the mammalian circadian clock. Prog Brain Res. 2012;199:1–18.
   PubMed Web of Science ®Google Scholar
• Güler AD, Ecker JL, Lall GS, et al. Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature. 2008;453(7191):102–105.
   PubMed Web of Science ®Google Scholar
• Lall GS, Revell VL, Momiji H, et al. Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance. Neuron. 2010;66(3):417–428.
   PubMed Web of Science ®Google Scholar
• Peirson SN, Halford S, Foster RG. The evolution of irradiance detection: melanopsin and the non-visual opsins. Philos Trans R Soc Lond B Biol Sci. 2009;364(1531):2849–2865.
   Web of Science ®Google Scholar
• Enezi J, Revell V, Brown T, Wynne J, Schlangen L, Lucas R. A “melanopic” spectral efficiency function predicts the sensitivity of melanopsin photoreceptors to polychromatic lights. J Biol Rhythms. 2011;26(4):314–323.
   PubMed Web of Science ®Google Scholar
• Altimus CM, Güler AD, Alam NM, et al. Rod photoreceptors drive circadian photoentrainment across a wide range of light intensities. Nat Neurosci. 2010;13(9):1107–1112.
   PubMed Web of Science ®Google Scholar
• Butler MP, Silver R. Divergent photic thresholds in the non-image-forming visual system: entrainment, masking and pupillary light reflex. Proc Biol Sci. 2011;278(1706):745–750.
   Web of Science ®Google Scholar
• Hattar S, Lucas RJ, Mrosovsky N, et al. Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature. 2003;424(6944):76–81.
   PubMed Web of Science ®Google Scholar
• Lucas RJ, Douglas RH, Foster RG. Characterization of an ocular photopigment capable of driving pupillary constriction in mice. Nat Neurosci. 2001;4(6):621–626.
   PubMed Web of Science ®Google Scholar
• Rollag MD, Berson DM, Provencio I. Melanopsin, ganglion-cell photoreceptors, and mammalian photoentrainment. J Biol Rhythms. 2003;18(3):227–234.
   Web of Science ®Google Scholar
• Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr. 2005;10(8):647–663; quiz 672.
   PubMed Web of Science ®Google Scholar
• Magnusson A, Kristbjarnarson H. Treatment of seasonal affective disorder with high-intensity light. A phototherapy study with an Icelandic group of patients. J Affect Disord. 1991;21(2):141–147.
   PubMed Web of Science ®Google Scholar
• Terman JS, Terman M, Schlager D, et al. Efficacy of brief, intense light exposure for treatment of winter depression. Psychopharmacol Bull. 1990;26(1):3–11.
   PubMedGoogle Scholar
• Meesters Y, Dekker V, Schlangen LJ, Bos EH, Ruiter MJ. Low-intensity blue-enriched white light (750 lux) and standard bright light (10,000 lux) are equally effective in treating SAD. A randomized controlled study. BMC Psychiatry. 2011;11:17.
   PubMed Web of Science ®Google Scholar
• Avery DH, Bolte MA, Dager SR, et al. Dawn simulation treatment of winter depression: a controlled study. Am J Psychiatry. 1993;150(1):113–117.
   PubMed Web of Science ®Google Scholar
• Terman M, Terman JS. Controlled trial of naturalistic dawn simulation and negative air ionization for seasonal affective disorder. Am J Psychiatry. 2006;163(12):2126–2133.
   PubMed Web of Science ®Google Scholar
• Avery DH, Kouri ME, Monaghan K, Bolte MA, Hellekson C, Eder D. Is dawn simulation effective in ameliorating the difficulty awakening in seasonal affective disorder associated with hypersomnia? J Affect Disord. 2002;69(1–3):231–236.
   Web of Science ®Google Scholar
• Rosenthal NE, Sack DA, Gillin JC, et al. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72–80.
   PubMed Web of Science ®Google Scholar
• Rosenthal NE. Diagnosis and treatment of seasonal affective disorder. JAMA. 1993;270(22):2717–2720.
   PubMed Web of Science ®Google Scholar
• Avery DH, Eder DN, Bolte MA, et al. Dawn simulation and bright light in the treatment of SAD: a controlled study. Biol Psychiatry. 2001;50(3):205–216.
   PubMed Web of Science ®Google Scholar
• Terman M, Terman JS. Circadian rhythm phase advance with dawn simulation treatment for winter depression. J Biol Rhythms. 2010;25(4):297–301.
   PubMed Web of Science ®Google Scholar
• Tuunainen A, Kripke DF, Endo T. Light therapy for non-seasonal depression. Cochrane Database Syst Rev. 2004;(2):CD004050.
   Google Scholar
• Even C, Schröder CM, Friedman S, Rouillon F. Efficacy of light therapy in nonseasonal depression: a systematic review. J Affect Disord. 2008;108(1–2):11–23.
   PubMed Web of Science ®Google Scholar
• Gallin PF, Terman M, Remé CE, Rafferty B, Terman JS, Burde RM. Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy. Am J Ophthalmol. 1995;119(2):202–210.
   Web of Science ®Google Scholar
• Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Hum Psychopharmacol. 2008;23(7):571–585.
   PubMed Web of Science ®Google Scholar
• Miller AL. Epidemiology, etiology, and natural treatment of seasonal affective disorder. Altern Med Rev. 2005;10(1):5–13.
   Google Scholar
• Pandi-Perumal SR, Trakht I, Srinivasan V, et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol. 2008;85(3):335–353.
   PubMed Web of Science ®Google Scholar
• Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R. Melatonin: nature’s most versatile biological signal? FEBS J. 2006;273(13):2813–2838.
   PubMed Web of Science ®Google Scholar
• Hickie IB, Rogers NL. Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet. 2011;378(9791):621–631.
   PubMed Web of Science ®Google Scholar
• Rice J, Mayor J, Tucker HA, Bielski RJ. Effect of light therapy on salivary melatonin in seasonal affective disorder. Psychiatry Res. 1995;56(3):221–228.
   Web of Science ®Google Scholar
• Lewy AJ, Sack RL, Miller LS, Hoban TM. Antidepressant and circadian phase-shifting effects of light. Science. 1987;235(4786):352–354.
   PubMed Web of Science ®Google Scholar
• Wehr TA, Duncan WC Jr, Sher L, et al. A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry. 2001;58(12):1108–1114.
   PubMed Web of Science ®Google Scholar
• Danilenko KV, Putilov AA, Russkikh GS, Duffy LK, Ebbesson SO. Diurnal and seasonal variations of melatonin and serotonin in women with seasonal affective disorder. Arctic Med Res. 1994;53(3):137–145.
   PubMedGoogle Scholar
• Murphy DG, Murphy DM, Abbas M, et al. Seasonal affective disorder: response to light as measured by electroencephalogram, melatonin suppression, and cerebral blood flow. Br J Psychiatry. 1993;163:327–331, 335–327.
   Google Scholar
• Partonen T, Vakkuri O, Lönnqvist J. Suppression of melatonin secretion by bright light in seasonal affective disorder. Biol Psychiatry. 1997;42(6):509–513.
   Web of Science ®Google Scholar
• Lewy AJ. Circadian misalignment in mood disturbances. Curr Psychiatry Rep. 2009;11(6):459–465.
   PubMed Web of Science ®Google Scholar
• Pail G, Huf W, Pjrek E, et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology. 2011;64(3):152–162.
   PubMed Web of Science ®Google Scholar
• Carlsson A, Svennerholm L, Winblad B. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand Suppl. 1980;280:75–85.
   PubMedGoogle Scholar
• Lambert GW, Reid C, Kaye DM, Jennings GL, Esler MD. Effect of sunlight and season on serotonin turnover in the brain. Lancet. 2002;360(9348):1840–1842.
   PubMed Web of Science ®Google Scholar
• Neumeister A, Praschak-Rieder N, Hesselmann B, et al. Effects of tryptophan depletion in fully remitted patients with seasonal affective disorder during summer. Psychol Med. 1998;28(2):257–264.
   PubMed Web of Science ®Google Scholar
• Neumeister A, Turner EH, Matthews JR, et al. Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry. 1998;55(6):524–530.
   PubMed Web of Science ®Google Scholar
• Lam RW, Zis AP, Grewal A, Delgado PL, Charney DS, Krystal JH. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry. 1996;53(1):41–44.
   PubMed Web of Science ®Google Scholar
• Neumeister A, Praschak-Rieder N, Hesselmann B, et al. Effects of tryptophan depletion in drug-free depressed patients who responded to total sleep deprivation. Arch Gen Psychiatry. 1998;55(2):167–172.
   Web of Science ®Google Scholar
• Lam RW, Bowering TA, Tam EM, et al. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in natural summer remission. Psychol Med. 2000;30(1):79–87.
   Web of Science ®Google Scholar
• Neumeister A, Praschak-Rieder N, Hesselmann B, et al. Rapid tryptophan depletion in drug-free depressed patients with seasonal affective disorder. Am J Psychiatry. 1997;154(8):1153–1155.
   Web of Science ®Google Scholar
• Partonen T, Lönnqvist J. Seasonal affective disorder. Lancet. 1998;352(9137):1369–1374.
   PubMed Web of Science ®Google Scholar
• McGrath RE, Buckwald B, Resnick EV. The effect of L-tryptophan on seasonal affective disorder. J Clin Psychiatry. 1990;51(4):162–163.
   PubMed Web of Science ®Google Scholar
• Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162(4):656–662.
   PubMed Web of Science ®Google Scholar
• Holsboer-Trachsler E, Hemmeter U, Hatzinger M, Seifritz E, Gerhard U, Hobi V. Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment – neurobiological and psychometric assessment of course. J Psychiatr Res. 1994;28(4):381–399.
   Web of Science ®Google Scholar
• Martiny K, Lunde M, Undén M, Dam H, Bech P. Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales. Acta Psychiatr Scand. 2005;112(2):117–125.
   PubMed Web of Science ®Google Scholar
• Beauchemin KM, Hays P. Phototherapy is a useful adjunct in the treatment of depressed in-patients. Acta Psychiatr Scand. 1997;95(5):424–427.
   Web of Science ®Google Scholar
• Loving RT, Kripke DF, Shuchter SR. Bright light augments antidepressant effects of medication and wake therapy. Depress Anxiety. 2002;16(1):1–3.
   Web of Science ®Google Scholar
• Benedetti F, Terman M. Much ado about … a moody clock. Biol Psychiatry. 2013;74(4):236–237.
   Web of Science ®Google Scholar
• Buckley TM, Schatzberg AF. A pilot study of the phase angle between cortisol and melatonin in major depression – a potential biomarker? J Psychiatr Res. 2010;44(2):69–74.
   PubMed Web of Science ®Google Scholar
• Deltito JA, Moline M, Pollak C, Martin LY, Maremmani I. Effects of phototherapy on non-seasonal unipolar and bipolar depressive spectrum disorders. J Affect Disord. 1991;23(4):231–237.
   Web of Science ®Google Scholar
• Wu JC, Kelsoe JR, Schachat C, et al. Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry. 2009;66(3):298–301.
   PubMed Web of Science ®Google Scholar
• Benedetti F, Barbini B, Fulgosi MC, et al. Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: acute response and long-term remission rates. J Clin Psychiatry. 2005;66(12):1535–1540.
   PubMed Web of Science ®Google Scholar
• Klemfuss H. Rhythms and the pharmacology of lithium. Pharmacology Ther. 1992;56(1):53–78.
   PubMed Web of Science ®Google Scholar
• Lemoine P, Zisapel N. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia. Expert Opin Pharmacother. 2012;13(6):895–905.
   PubMed Web of Science ®Google Scholar
• Kawabe K, Horiuchi F, Oka Y, Ueno S. The melatonin receptor agonist ramelteon effectively treats insomnia and behavioral symptoms in autistic disorder. Case Rep Psychiatry. 2014;2014:561071.
   Google Scholar
• Hardeland R. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders. Curr Opin Investig Drugs. 2009;10(7):691–701.
   Google Scholar
• NICE. Depression: the treatment and management of depression in adults (update). National Institute for Health and Clinical Excellence; 2009;CG23. Available from http://www.nice.org.uk/guidance/cg90/resources/guidance-depression-in-adults-pdf. Accessed September 11, 2014.
   Google Scholar
• Coplan JD, Gopinath S, Abdallah CG, Berry BR. A neurobiological hypothesis of treatment-resistant depression – mechanisms for selective serotonin reuptake inhibitor non-efficacy. Front Behav Neurosci. 2014;8:189.
   PubMed Web of Science ®Google Scholar
• Sprouse J, Braselton J, Reynolds L. Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biol Psychiatry. 2006;60(8):896–899.
   PubMed Web of Science ®Google Scholar
• Westrich L, Sprouse J, Sánchez C. The effects of combining serotonin reuptake inhibition and 5-HT7 receptor blockade on circadian rhythm regulation in rodents. Physiol Behav. 2013;110–111:42–50.
   Web of Science ®Google Scholar
• Kepser LJ, Homberg JR. The neurodevelopmental effects of serotonin: a behavioural perspective. Behav Brain Res. Epub May 23, 2014.
   Google Scholar
• López-Torres J, Párraga I, Del Campo JM, Villena A; ADSCAMFYC Group. Follow up of patients who start treatment with antidepressants: treatment satisfaction, treatment compliance, efficacy and safety. BMC Psychiatry. 2013;13:65.
   Web of Science ®Google Scholar
• Pjrek E, Winkler D, Konstantinidis A, Willeit M, Praschak-Rieder N, Kasper S. Agomelatine in the treatment of seasonal affective disorder. Psychopharmacology (Berl). 2007;190(4):575–579.
   PubMed Web of Science ®Google Scholar